November 2023 Medical News Summary
Listen now
Description
Why Physicians Don’t Deprescribe Medicines; What to Know About Wegovy’s Rare but Serious Adverse Effects; What to Know About Zepbound, the Newest Antiobesity Drug Related Content: As Semaglutide’s Popularity Soars, Rare but Serious Adverse Effects Are Emerging FDA Green-Lights Tirzepatide, Marketed as Zepbound, for Chronic Weight Management Deciding When It’s Better to Deprescribe Medicines Than to Continue Them
More Episodes
College Athlete Deaths by Suicide Have Doubled; Why the Bird Flu Outbreak in Dairy Cows Matters; Combined COVID-19 and Flu Vaccines Could Be Available Next Year Related Content: College Athlete Deaths by Suicide Have Doubled, and Researchers Want to Know Why Bird Flu Outbreak in Dairy Cows...
Published 05/31/24
Published 05/31/24
Can AI augment radiological processes, imaging analysis, and diagnosis? In this Q&A, Saurabh Jha, MBBS, MRCS, MS, an associate professor of radiology at the University of Pennsylvania, joins JAMA's Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, to discuss how AI could play a crucial...
Published 05/24/24